Estimated effect-site concentration (EC95) of remifentanil for i-gel insertion without neuromuscular blockade during remimazolam inductio
Not Applicable
Recruiting
- Conditions
- Not Applicable
- Registration Number
- KCT0006968
- Lead Sponsor
- Gachon University Gil Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
? Ages 19-65
? ASA 1, 2
? Those who are scheduled for surgery using i-gel LMA as an airway maintainer under general anesthesia
Exclusion Criteria
? Those who are allergic to drugs used during the study
? Research subjects with high risk of aspiration
- hiatus hernia, gastro-esophageal reflux disease, non-fasting status
? When endotracheal intubation is expected to be difficult
- Restriction of mouth opening, restriction of cervical extension, Mallampati class IV
? Severe obesity (BMI>35 kg/m2)
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method EC95 of remifentanil
- Secondary Outcome Measures
Name Time Method